Mplexity

mplexity originates and develops biotech companies that target medical breakthroughs. > Develops concepts around molecular assets or target diseases > Manages interests (usually ≥10% equity) in the resultant companies > Therapeutic areas: CNS, cardiovascular/metabolic, oncology, liver disease > Focus on de-risked assets or new mechanisms; sometimes both > Built around a core team of five managers with >100 years of collective industry experience